Esranur Aydın

7PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyMedical mycologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 06, 2025
Precision-Guided Durable Response From Venetoclax With Decitabine in a Patient With a Metastatic Refractory IDH2-Mutant Cholangiocarcinoma.

Eylül Özgü, Ünal Metin Tokat, Ashkan Adibi

|Nov 14, 2024
Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety.

Ünal Metin Tokat, Şevval Nur Bilgiç, Esranur Aydın

|Oct 25, 2024
Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers.

Ünal Metin Tokat, Ashkan Adibi, Esranur Aydın

|Apr 22, 2024
Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations.

Esranur Aydın, Ünal Metin Tokat, Eylül Özgü

|Dec 21, 2023
Exceptional Response to MEK Inhibition in a Patient With RAF1-Mutant Myxofibrosarcoma: Case Report and Mechanistic Overview.

Eylül Özgü, Esranur Aydin, Ashkan Adibi

|Dec 18, 2023
PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview.

Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü

Pageof 2

Frequent Collaborators

6 joint publications

Mutlu Demiray

5 joint publications

Eylül Özgü

5 joint publications

Ashkan Adibi

4 joint publications

Ünal Metin Tokat